Annual SGA
$37.93 M
+$6.85 M+22.06%
December 31, 2024
Summary
- As of March 10, 2025, AKRO annual SGA is $37.93 million, with the most recent change of +$6.85 million (+22.06%) on December 31, 2024.
- During the last 3 years, AKRO annual SGA has risen by +$18.80 million (+98.29%).
- AKRO annual SGA is now at all-time high.
Performance
AKRO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$8.73 M
-$739.00 K-7.80%
December 31, 2024
Summary
- As of March 10, 2025, AKRO quarterly SGA is $8.73 million, with the most recent change of -$739.00 thousand (-7.80%) on December 31, 2024.
- Over the past year, AKRO quarterly SGA has dropped by -$739.00 thousand (-7.80%).
- AKRO quarterly SGA is now -20.65% below its all-time high of $11.00 million, reached on September 30, 2022.
Performance
AKRO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.89 B
-$252.06 M-9.54%
December 31, 2024
Summary
- As of March 10, 2025, AKRO TTM SGA is -$2.89 billion, with the most recent change of -$252.06 million (-9.54%) on December 31, 2024.
- Over the past year, AKRO TTM SGA has dropped by -$2.93 billion (-7779.24%).
- AKRO TTM SGA is now -3242.18% below its all-time high of -$86.56 million.
Performance
AKRO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AKRO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.1% | -7.8% | -7779.2% |
| 3 y3 years | +98.3% | +84.7% | -10000.0% |
| 5 y5 years | +340.7% | +183.2% | -10000.0% |
AKRO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.3% | -20.6% | +84.7% | -171.3% | at low |
| 5 y | 5-year | at high | +340.7% | -20.6% | +183.2% | -563.4% | at low |
| alltime | all time | at high | +1900.3% | -20.6% | +4377.9% | -3242.2% | at low |
Akero Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $37.93 M(+22.1%) | $8.73 M(-7.8%) | $37.93 M(+0.7%) |
| Sep 2024 | - | $9.47 M(-9.1%) | $37.67 M(+4.1%) |
| Jun 2024 | - | $10.42 M(+12.0%) | $36.19 M(+8.3%) |
| Mar 2024 | - | $9.30 M(+9.7%) | $33.41 M(+7.5%) |
| Dec 2023 | $31.07 M(+4.0%) | $8.48 M(+6.3%) | $31.07 M(+4.7%) |
| Sep 2023 | - | $7.98 M(+4.4%) | $29.69 M(-9.2%) |
| Jun 2023 | - | $7.64 M(+9.7%) | $32.71 M(+4.5%) |
| Mar 2023 | - | $6.97 M(-1.9%) | $31.30 M(+4.8%) |
| Dec 2022 | $29.87 M(+56.2%) | $7.10 M(-35.5%) | $29.87 M(+8.6%) |
| Sep 2022 | - | $11.00 M(+76.6%) | $27.50 M(+28.6%) |
| Jun 2022 | - | $6.23 M(+12.5%) | $21.38 M(+6.2%) |
| Mar 2022 | - | $5.54 M(+17.1%) | $20.14 M(+5.3%) |
| Dec 2021 | $19.13 M | $4.73 M(-3.2%) | $19.13 M(+3.5%) |
| Sep 2021 | - | $4.88 M(-2.1%) | $18.47 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $4.99 M(+10.3%) | $17.75 M(+9.7%) |
| Mar 2021 | - | $4.53 M(+11.1%) | $16.18 M(+6.2%) |
| Dec 2020 | $15.24 M(+77.1%) | $4.07 M(-2.0%) | $15.24 M(+7.0%) |
| Sep 2020 | - | $4.16 M(+21.7%) | $14.25 M(+13.9%) |
| Jun 2020 | - | $3.42 M(-4.8%) | $12.51 M(+16.5%) |
| Mar 2020 | - | $3.59 M(+16.4%) | $10.74 M(+24.9%) |
| Dec 2019 | $8.61 M(+353.9%) | $3.08 M(+27.2%) | $8.61 M(+32.2%) |
| Sep 2019 | - | $2.42 M(+47.0%) | $6.51 M(+42.8%) |
| Jun 2019 | - | $1.65 M(+13.8%) | $4.56 M(+44.7%) |
| Mar 2019 | - | $1.45 M(+47.1%) | $3.15 M(+66.1%) |
| Dec 2018 | $1.90 M | $985.00 K(+107.8%) | $1.90 M(+108.1%) |
| Sep 2018 | - | $474.00 K(+95.9%) | $911.00 K(+108.5%) |
| Jun 2018 | - | $242.00 K(+24.1%) | $437.00 K(+124.1%) |
| Mar 2018 | - | $195.00 K | $195.00 K |
FAQ
- What is Akero Therapeutics annual SGA?
- What is the all time high annual SGA for Akero Therapeutics?
- What is Akero Therapeutics annual SGA year-on-year change?
- What is Akero Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Akero Therapeutics?
- What is Akero Therapeutics quarterly SGA year-on-year change?
- What is Akero Therapeutics TTM SGA?
- What is the all time high TTM SGA for Akero Therapeutics?
- What is Akero Therapeutics TTM SGA year-on-year change?
What is Akero Therapeutics annual SGA?
The current annual SGA of AKRO is $37.93 M
What is the all time high annual SGA for Akero Therapeutics?
Akero Therapeutics all-time high annual SGA is $37.93 M
What is Akero Therapeutics annual SGA year-on-year change?
Over the past year, AKRO annual SGA has changed by +$6.85 M (+22.06%)
What is Akero Therapeutics quarterly SGA?
The current quarterly SGA of AKRO is $8.73 M
What is the all time high quarterly SGA for Akero Therapeutics?
Akero Therapeutics all-time high quarterly SGA is $11.00 M
What is Akero Therapeutics quarterly SGA year-on-year change?
Over the past year, AKRO quarterly SGA has changed by -$739.00 K (-7.80%)
What is Akero Therapeutics TTM SGA?
The current TTM SGA of AKRO is -$2.89 B
What is the all time high TTM SGA for Akero Therapeutics?
Akero Therapeutics all-time high TTM SGA is -$86.56 M
What is Akero Therapeutics TTM SGA year-on-year change?
Over the past year, AKRO TTM SGA has changed by -$2.93 B (-7779.24%)